Cargando…
Structure function characterization of SARS CoV2 proteases for COVID19 antiviral development
Autores principales: | Greene-Cramer, Rebecca, Bafna, Khushboo, White, Kris, Harish, Balasubramanian, Rosales, Romel, Ramelot, Theresa, Acton, Thomas B., Del Olmo, Elena Moreno, Kehrer, Thomas, Miorin, Lisa, Royer, Catherine A., Garcia-Sastre, Adolfo, Krug, Robert, Montelione, Gaetano T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biophysical Society. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833058/ http://dx.doi.org/10.1016/j.bpj.2021.11.2568 |
Ejemplares similares
-
Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture
por: Bafna, Khushboo, et al.
Publicado: (2021) -
Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir
por: Bafna, Khushboo, et al.
Publicado: (2021) -
Structural Similarity of SARS-CoV2 M(pro) and HCV NS3/4A Proteases Suggests New Approaches for Identifying Existing Drugs Useful as COVID-19 Therapeutics
por: Bafna, Khushboo, et al.
Publicado: (2020) -
Structural similarities between SARS-CoV2 3CL(pro) and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals
por: Bafna, Khushboo, et al.
Publicado: (2022) -
Protocol for production and purification of SARS-CoV-2 3CL(pro)
por: Mazzei, Luca, et al.
Publicado: (2023)